Key Points

HIV Infections and AIDS

• HIV Surveillance Systems

  • Increasing the completeness of mandatory reporting (MR)

  • Increased participation of laboratories in LaboVIH

• HIV testing

  • Increase in screening rates, most pronounced among men and those over 50

  • Significant increase in uptake of the VIHTest program among those over 25

• HIV diagnosis

  • 420 new HIV-positive cases identified in 2023, an increase since 2021

  • Increase among heterosexual individuals born abroad or in France

  • Decrease in the number of new HIV diagnoses among men who have sex with men (MSM) born in France

• HIV incidence, time to diagnosis, and size of the undiagnosed population

  • Stabilization of HIV incidence since 2021

  • Median time between infection and diagnosis estimated at 2 years

  • By the end of 2023, 740 people in Auvergne-Rhône-Alpes will be living with HIV without knowing their HIV status

• New cases of people living with HIV

  • Increase in the number of new cases since 2021, more pronounced in the Alpine Arc region

• AIDS diagnosis

  • No significant change in the number of AIDS diagnoses

Bacterial STIs

• STI screening

  • Increase in screening rates for all bacterial STIs, across all age groups

• STI diagnosis

  • Chlamydia trachomatis infections remain the most common STIs (diagnosis rate of 63 per 100,000 inhabitants), followed by gonococcal infections (24 per 100,000) and syphilis (6 per 100,000)

  • Slight increase in diagnosis rates for Chlamydia trachomatis infections, primarily among men and particularly those over 50

  • A sharp increase in gonorrhea diagnosis rates (greater than the increase in screening rates), more pronounced among men, particularly those over 50

  • Increase in syphilis diagnosis rates among men of all ages and among women aged 15–25 and over 50